LivaNova and Verily Announce First Patient Enrolled in Study to Evaluate Treatment Effectiveness for Patients Living with Depression
Go back to LivaNova and Verily Announce First Patient Enrolled in Study to Evaluate Treatment Effectiveness for Patients Living with Depression| (NASDAQ: LIVN) | Delayed: 78.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.50 | 52 Week High | $63.21 | |||
| Open | $78.50 | 52 Week Low | $41.17 | |||
| Day High | $78.50 | P/E | N/A | |||
| Day Low | $78.50 | EPS | $0.00 | |||
| Volume | 135 | |||||
